Literature DB >> 31520292

Two-year follow-up of one-stage left unilateral thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation.

Carlo de Asmundis1, Varnavas Varnavas2, Juan Sieira2, Erwin Ströker2, Henrique E Coutiño2, Muryo Terasawa2, Juan Pablo Abugattas2, Francesca Salghetti2, Riccardo Maj2, Osório Thiago Guimarães2, Saverio Iacopino2, Vincent Umbrain3, Jan Poelaert3, Pedro Brugada2, Sandro Gelsomino4, Gian-Battista Chierchia2, Mark La Meir5.   

Abstract

PURPOSE: The purpose of this study was to analyze the efficacy and complication rates of a one-stage left unilateral thoracoscopic hybrid procedure in a series of patients with persistent and long-standing persistent atrial fibrillation (AF) in a 2-year follow-up.
METHODS: Fifty-one consecutive patients (34 males, 65.7 ± 8 years) having undergone hybrid isolation of pulmonary veins (PVs) and posterior wall of left atrium (LA) by means of left unilateral hybrid thoracoscopic ablation for symptomatic persistent (n = 22, 43%) and long-standing persistent atrial fibrillation (AF) (n = 29, 57%) were analyzed.
RESULTS: At a mean follow-up of 24.9 ± 11.8 months (median 24), the success rate without antiarrhythmic therapy was achieved in 68.6% of patients. Procedure-related major complications were observed in 2 patients (4%) including diaphragmatic perforation and late pericardial tamponade requiring mini left-sided thoracotomy and pericardial drainage, respectively. The success rate did not significantly differ between persistent and long-standing persistent AF (respectively, 68.2 and 69%; P = 0.89). Patients with AF relapse during the blanking period were 3.8 times more likely to have AF recurrence after 3 months from the ablation procedure.
CONCLUSION: The hybrid one-stage left unilateral thoracoscopic procedure exhibits encouraging results in the setting of both persistent and long-standing persistent AF after a 2-year follow-up, at a low rate of adverse events.

Entities:  

Keywords:  Left unilateral hybrid ablation; Long-standing persistent atrial fibrillation; Persistent atrial fibrillation

Year:  2019        PMID: 31520292     DOI: 10.1007/s10840-019-00616-w

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  7 in total

1.  Characterizing Recurrence Following Hybrid Ablation in Patients With Persistent Atrial Fibrillation.

Authors:  David C Kress; Lynn Erickson; Tadele W Mengesha; David Krum; Jasbir Sra
Journal:  J Patient Cent Res Rev       Date:  2020-07-27

Review 2.  A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent.

Authors:  Riyaz A Kaba; Omar Ahmed; Elijah Behr; Aziz Momin
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

3.  Ablation of persistent atrial fibrillation: the added value of hybrid.

Authors:  Bart Maesen; Elham Bidar; Justin Glm Luermans; Jos G Maessen
Journal:  Eur J Cardiothorac Surg       Date:  2021-07-30       Impact factor: 4.191

Review 4.  Surgery and Catheter Ablation for Atrial Fibrillation: History, Current Practice, and Future Directions.

Authors:  Patrick M McCarthy; James L Cox; Olga N Kislitsina; Jane Kruse; Andrei Churyla; S Chris Malaisrie; Christopher K Mehta
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

Review 5.  A narrative review of hybrid ablation for persistent and longstanding persistent atrial fibrillation.

Authors:  Ali Khoynezhad; Nikhil Warrier; Tiffany Worthington; Adrian Shandling
Journal:  Ann Transl Med       Date:  2021-06

6.  In vivo preliminary test of a new biparietal bidirectional bipolar radiofrequency magnetic coupling system.

Authors:  Francesco Matteucci; Mark La Meir; Bart Maesen; Gian-Battista Chierchia; Carlo De Asmundis; Sandro Gelsomino
Journal:  Pacing Clin Electrophysiol       Date:  2021-08-02       Impact factor: 1.912

7.  European multicentre experience of staged hybrid atrial fibrillation ablation for the treatment of persistent and longstanding persistent atrial fibrillation.

Authors:  G A Haywood; R Varini; P Osmancik; M Cireddu; J Caldwell; M A Chaudhry; M Loubani; P Della Bella; E Lapenna; P Budera; M Dalrymple-Hay
Journal:  Int J Cardiol Heart Vasc       Date:  2020-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.